Sara Siddall

Colorectal cancer is one of the most common cancers globally, but when detected early, it is highly treatable. Awareness, regular screening, and ongoing research are key to improving outcomes and saving lives. #ColorectalCancerAwareness #CancerPrevention #GetScreened

We’re thrilled to announce Biodexa's close of a licensing deal for a novel molecular glue targeting GIST, from Otsuka Pharmaceutical. MTX240 expands our rare disease pipeline tinyurl.com/34a45rys #RareDiseases #Oncology #MolecularGlue #GIST #DrugDiscovery #Partnerships #BDRX

I still don’t understand why just because roads haven’t been adopted by @cardiffcouncil that rules can be broken and common decency can’t be questioned. Good luck to wheelchair users and people with pushchairs around Cardiff Bay and Porth Teigr. @swpolice

Devastating news from Penarth

@Girvla @PenarthRFC @PenarthAthletic @Springboks @Barbarian_FC Absolutely awful, so sad #Penarth

Absolutely devastated. A fire overnight has destroyed @PenarthRFC @PenarthAthletic. The building can be replaced but so much irreplaceable history has gone including the Springbok head presented by @Springboks to @Barbarian_FC.

Looking forward to attending @CGAIGC 2025 annual meeting in St. Louis this week. An informative meeting that brings together care providers, scientists, and like-minded partners to improve the diagnosis, treatment, and care of individuals with hereditary gastrointestinal cancer.

We are pleased to announce the enrolment of the first two patients by the Pan American Center for Oncology Trials in San Juan, Puerto Rico into our pivotal Phase 3 Serenta Trial of eRapa in patients with familial adenomatous polyposis (FAP). rb.gy/it73su

We are pleased to announce the activation of the first clinical site in the Serenta trial for patients with Familial Adenomatous Polyposis (FAP). For more information about the trial please see serentatrial.com #BDRX

We are excited to introduce 𝐒𝐞𝐫𝐞𝐧𝐭𝐚, the name of our upcoming clinical study focused on advancing care for individuals with familial adenomatous polyposis (FAP) serentatrial.com #BDRX #clinicaltrial

This week is FAP Awareness Week 2025 - a time to shine a light on Familial Adenomatous Polyposis (FAP), a rare hereditary condition that significantly increases the risk of colorectal cancer. shorturl.at/GkNZ6 #Cancer #PatientAdvocacy #PatientAwareness #hereditarycancers

Once again @cardiffcouncil misleading traffic warning signs causing congestion on A4232 into Cardiff Bay. #highways #Cardiff

We are happy to announce the recruitment of the first patient in our Phase 2 study of Tolimidone in Type 1 Diabetes (T1D). The study is an Investigator Initiated Trial (IIT) conducted by the University of Alberta Diabetes Institute. rb.gy/tm5xpl #clinicaltrial #BDRX

With fast track designation in hand, a successful protocol discussion with FDA, and CROs in place, we are on track to initiate our funded Phase 3 Trial in FAP in the next quarter. benzinga.com/partner/biotec… #Biodexa #eRapa #Clinical #FAP #Cancer #Colon #FDA #CRO #Phase3

We are looking forward to attending @DCATorg Week in New York. We are seeking a CDMO to support the development and commercial manufacture of eRapa, our novel formulation for treating patients with Familial Adenomatous Polyposis (FAP) #DCATWeek2025 #Manufacturing #nanoparticle

We are pleased to announce the successful outcome of a Type C Meeting with FDA regarding the Phase 3 Program for eRapa in FAP. This clears the way to finalize Phase 3 protocol and recruit sites for the U.S. shorturl.at/T7C6X #eRapa #FAP #ClinicalTrials #Biodexa #BDRX

We are looking forward to attending #BIOEuropeSpring in Milan. We are developing a pipeline of treatments aimed at diseases with high unmet clinical need. We are excited to share our progress with our first pivotal study for our lead programme in FAP #ColonCancer #Cancer

March is Colorectal Cancer Awareness Month and we are dedicated to transforming the future of familial adenomatous polyposis (FAP) treatment. Biodexa is working hard to offer patients new treatment options that have the potential to delay or avoid the need for surgery. #FAP

Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis #FAP #eRapa biodexapharma.com/biodexa-receiv…

We’re happy to share that we'll re-open tomorrow! 😀 Thank you for your patience while we addressed the issue, and we apologise for any inconvenience it caused. If you’d like to know more about why we closed temporarily, please read our statement bit.ly/4hMdMS5

Quizzers of Penarth and Vale of Glamorgan. Come and support @RNLIPenarth at Penarth Yacht Club. If possible please buy tickets in advance at the RNLI Shop with cash. #SavingLivesAtSea #RNLI #community #charity